233 related articles for article (PubMed ID: 7577376)
1. Current status of vinorelbine for breast cancer.
Smith GA
Oncology (Williston Park); 1995 Aug; 9(8):767-73; discussion 774, 776, 779. PubMed ID: 7577376
[TBL] [Abstract][Full Text] [Related]
2. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
Kubota K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy.
Mano M
Cancer Treat Rev; 2006 Apr; 32(2):106-18. PubMed ID: 16473470
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
5. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
6. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
Aapro MS
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
Chang AY; Garrow GC
Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
Crawford J
Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
[TBL] [Abstract][Full Text] [Related]
9. UFT/leucovorin plus vinorelbine combination for advanced breast cancer.
Fumoleau P; Déporte R; Kerbrat P; Bonneterre J; Fargeot P
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):50-5. PubMed ID: 11098494
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
Vogel CL
Semin Oncol; 1995 Apr; 22(2 Suppl 5):61-5. PubMed ID: 7740335
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trials of vnorelbine in breast cancer--its scientific usefulness and development history until regulatory approval].
Tominaga T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):541-7. PubMed ID: 16612169
[TBL] [Abstract][Full Text] [Related]
13. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
14. Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine.
Aapro MS; Harper P; Johnson SA; Vermorken JB
Crit Rev Oncol Hematol; 2001 Dec; 40(3):251-63. PubMed ID: 11738948
[TBL] [Abstract][Full Text] [Related]
15. Vinorelbine/paclitaxel combination studied in treatment of metastatic breast cancer patients.
Oncology (Williston Park); 1995 Jun; 9(6):518, 543. PubMed ID: 8719098
[No Abstract] [Full Text] [Related]
16. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
Vokes EE
Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
[TBL] [Abstract][Full Text] [Related]
17. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine tartrate: a promising new chemotherapeutic agent.
Baldwin PD
J Intraven Nurs; 1996; 19(1):16-27. PubMed ID: 8708838
[TBL] [Abstract][Full Text] [Related]
19. New options in the treatment of non-small cell lung cancer.
Fossella F; Rigas JR; Belani CP
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.
Martin M; Casado A; Perez Segura P; Garcia Carbonero I; Diaz-Rubio E
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):28-30. PubMed ID: 9516600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]